This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Browse

Methylin

Emerging

Methylin = Ritalin IR with a different label on the bottle.

Aliases (8)

Methylphenidate IR · Methylin IR · Methylin chewable · Methylin oral solution · Mallinckrodt methylphenidate · MPH-IR (Methylin) · methylphenidate hydrochloride · dl-threo-methylphenidate (Mallinckrodt brand)

TYPICAL DOSE

10-20 mg/day

BID/TID

ROUTE

Oral (tablet)

Oral

CYCLE

Per prescriber

As prescribed

STORAGE

Room temp; original container

Room temp

Overview

What is Methylin?

Methylin is a brand of immediate-release methylphenidate, a piperidine-class CNS stimulant. It is FDA-approved for ADHD and narcolepsy.

Key Benefits

Improves attention, focus, and impulse control in ADHD, increases on-task behavior and academic performance, reduces excessive daytime sleepiness in narcolepsy, and provides a shorter-acting alternative to extended-release formulations.

Mechanism of Action

Blocks the dopamine and norepinephrine reuptake transporters (DAT and NET) in the prefrontal cortex and striatum, raising synaptic catecholamine levels and enhancing prefrontal signal-to-noise. Effects are dose- and timing-dependent with limited release of vesicular dopamine.

Pharmacokinetics

PeakHalf-life

Approximate curve — visual aid only, not data-precise PK

▸Brand options5 known

Methylphenidate IRMethylin IRMethylin chewableMethylin oral solutionMallinckrodt methylphenidate

StatusSchedule II (US DEA) | Class B (UK) | Schedule III (Canada CDSA) — Rx-required everywhere

Research Indications

Most Effective

Racemic d/l-threo-methylphenidate

competitive DAT + NET reuptake inhibitor; d-isomer carries ~all CNS activity, l-isomer ~10× weaker and ~95% presystemically hydrolyzed by…

Quality Indicators

✓

Pharmacy-dispensed, intact packaging

Prescription tablets in original sealed packaging from a licensed pharmacy.

Generic vs branded

Generics are usually fine but bioavailability can vary slightly; track if you switch.

✗

Unbranded blister or counterfeit risk

Counterfeit pharmaceuticals are a known issue; verify pharmacy and lot if buying internationally.

What to Expect

Onset
20-45 min (slightly faster with oral solution, ~30 min)
Peak
1-2 hr post-dose

Side Effects & Safety

Identical to Ritalin IR side-effect profile. See ritalin.md "Side effects + risks" section. Brief recap:

Common: appetite suppression, insomnia (if late dosing), headache, dry mouth, jitteriness, mild HR/BP elevation (5-15 bpm, 3-7 mmHg)
Less common: anxiety, mood lability, bruxism, tics (rare in adults), weight loss
Rare-serious: cardiovascular events (~10% relative increase first 6 months per 2024 JAMA Network Open n=252k cohort), psychiatric (psychosis/mania), priapism, Raynaud's-like vasculopathy
Watch periods: first 4 weeks (titration), first 6 months (CV event window)

Methylin-specific side-effect notes:

Chewable tablet form: rare reports of oral mucosal irritation from grape flavoring excipients; not clinically significant
Oral solution: contains sucrose — relevant for diabetics or patients on sugar-restricted diets